Court Gives Biopharma Patent Owners (A Little) Help In Inter Partes Review
Executive Summary
In 9-4 en banc opinion, Federal Circuit finds PTAB decision that an inter partes review petition is not time-barred can be appealed; says Supreme Court left opening in Cuozzo ruling.